1 Mega-Cap Stock Worth Your Attention and 2 to Keep Off Your Radar "Too big to fail" is how we would describe the megacap stocks in this article today.
While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their ability to find new sources of growth.
Jensen Huang, Magic Johnson, Patrick Dempsey, Linda Yaccarino And More Bigwigs Headline Milken Global Conference 2025: What You Need To Know The Milken Institute's 28th annual Global Conference, featuring prominent figures like Jensen Huang, Magic Johnson, and Linda Yaccarino, is focusing on key global issues such as AI, healthcare, and climate resilience.
If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again? Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year?
If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy AbbVie is well-positioned for industry-leading growth, as Skyrizi and Rinvoq sales outperform, driving system-wide growth alongside a diversified portfolio.
What To Expect From Penumbra’s (PEN) Q1 Earnings Medical device company Penumbra (
NYSE:PEN )
will be reporting results tomorrow after the bell. Here’s what investors should know.
Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow Medical device company ResMed (
NYSE:RMD )
will be announcing earnings results tomorrow after market close. Here’s what to look for.
What To Expect From Boston Scientific’s (BSX) Q1 Earnings Medical device company Boston Scientific (
NYSE:BSX )
will be reporting results tomorrow before market open. Here’s what to look for.
Earnings To Watch: Intuitive Surgical (ISRG) Reports Q1 Results Tomorrow Medical technology company Intuitive Surgical (
NASDAQ:ISRG ) will be reporting results tomorrow after market close. Here’s what investors should know.
Dividend Stock Analysis: Abbott Laboratories The company is focused on nutritionals, diagnostics, generic drugs, and medical devices.
5 Dividend Aristocrats® So Good You'll Never Want to Sell Turn $180 into $7M? These 5 Dividend Aristocrats show how it's possible.
Tariff-Resistant Abbott Laboratories on Track for New Highs Abbott Laboratories stock price is on track to hit a new high in 2025 and could do it before the end of the first half. Dividends and buybacks help.
Healthcare Sector Update: MEDtech And Diagnostics Amidst the tariff chaos, we may get clues from one of the most defensive sectors of the market-healthcare stocks.
Stay informed with the top movers within the S&P500 index on Wednesday. Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.
Stocks Sink As Powell Dismisses 'Fed Put' Safety Net, Gold Extends Massive Lead Over Nasdaq Powell says tariffs could lead to higher inflation and slower growth, but Fed won't intervene in market losses. Stocks tumble, gold prices rise.
Discover which S&P500 stocks are making waves on Wednesday. Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.
